Workflow
Halozyme to Host Investor Conference Call to Provide Updated 2025 Financial Guidance
HALOHalozyme(HALO) Prnewswire·2025-01-06 21:30

SAN DIEGO, Jan. 6, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will host an Investor Conference Call on Wednesday, January 8, 2025, at 5:30 a.m. PT / 8:30 a.m. ET.On the call, Dr. Helen Torley, President and Chief Executive Officer, and Nicole LaBrosse, Chief Financial Officer, will provide preliminary unaudited full year 2024 results and updated 2025 and multi-year financial guidance.Pre-registration of the live call can be accessed via link here: https:/ ...